Litigation Details for Sanofi-Aventis U.S. LLC v. Sandoz Inc. (D. Del. 2020)
✉ Email this page to a colleague
Sanofi-Aventis U.S. LLC v. Sandoz Inc. (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-06-12 |
| Court | District Court, D. Delaware | Date Terminated | 2023-07-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 10,583,110; 7,241,907; 8,927,592 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Sandoz Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Sanofi-Aventis U.S. LLC v. Sandoz Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-09-09 | 107 | *989 This appeal involves U.S. Patent No. 8,927,592 (“the ’592 patent”), which is assigned to Sanofi …claims 1–5 and 7–30 of U.S. Patent No. 8,927,592 (Ex. 1001, “the ’592 patent”). Paper 3 (“Petition” …1365 IPR2016-00712 Patent 8,927,592 B2 Patent Owner filed a Reply to Petitioner…1366 IPR2016-00712 Patent 8,927,592 B2 17, 2017, Patent Owner appealed to the Court of…claims 21 and 30 of U.S. Patent No. 8,927,592 (“the ’592 patent”) under 35 U.S.C. § | External link to document | |
| 2020-11-03 | 143 | Redacted Document | 11/03/20 Page 8 of 27 PageID #: 2085 8,927,592 Methods of treating a …Orange Book-listed patents, including the ’170 patent and ’907 patent. Ex. 15, Patent Cert. Pursuant to… Count I: Infringement of U.S. Patent No. 10,583,110 (“’110 patent”) under 35 U.S.C. § 271…110 patent under 35 U.S.C. § 271(b); • Count III: Infringement of U.S. Patent No. …of Sanofi as to the ’170 patent, but vacated the judgment on the ’592 patent for the disclaimed claims | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
